Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock - Currency: USD

123.59  -2.9 (-2.29%)

After market: 123.59 0 (0%)

Fundamental Rating

6

Overall DORM gets a fundamental rating of 6 out of 10. We evaluated DORM against 83 industry peers in the Automobile Components industry. DORM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DORM has a decent growth rate and is not valued too expensively. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
DORM had a positive operating cash flow in the past year.
In the past 5 years DORM has always been profitable.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

1.2 Ratios

DORM has a better Return On Assets (7.86%) than 91.57% of its industry peers.
Looking at the Return On Equity, with a value of 15.05%, DORM belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.76%, DORM belongs to the best of the industry, outperforming 92.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 9.58%.
The 3 year average ROIC (9.08%) for DORM is below the current ROIC(11.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.86%
ROE 15.05%
ROIC 11.76%
ROA(3y)6.23%
ROA(5y)7.1%
ROE(3y)12.27%
ROE(5y)12.03%
ROIC(3y)9.08%
ROIC(5y)9.73%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 9.43%, DORM belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
DORM's Profit Margin has declined in the last couple of years.
DORM's Operating Margin of 14.41% is amongst the best of the industry. DORM outperforms 97.59% of its industry peers.
DORM's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 39.54%, DORM belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
In the last couple of years the Gross Margin of DORM has declined.
Industry RankSector Rank
OM 14.41%
PM (TTM) 9.43%
GM 39.54%
OM growth 3Y-0.77%
OM growth 5Y-7.46%
PM growth 3Y-11.86%
PM growth 5Y-13.36%
GM growth 3Y0.43%
GM growth 5Y-1.52%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
Compared to 1 year ago, DORM has less shares outstanding
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 4.28. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
DORM has a better Altman-Z score (4.28) than 89.16% of its industry peers.
The Debt to FCF ratio of DORM is 3.03, which is a good value as it means it would take DORM, 3.03 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DORM (3.03) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.42 indicates that DORM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.42, DORM is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.03
Altman-Z 4.28
ROIC/WACC1.25
WACC9.41%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.34 indicates that DORM has no problem at all paying its short term obligations.
DORM has a better Current ratio (2.34) than 79.52% of its industry peers.
A Quick Ratio of 1.16 indicates that DORM should not have too much problems paying its short term obligations.
DORM has a Quick ratio of 1.16. This is in the better half of the industry: DORM outperforms 73.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.16
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.57%, which is quite impressive.
Measured over the past 5 years, DORM shows a small growth in Earnings Per Share. The EPS has been growing by 1.52% on average per year.
Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 1.70% in the last year.
DORM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.66% yearly.
EPS 1Y (TTM)63.57%
EPS 3Y9.48%
EPS 5Y1.52%
EPS Q2Q%40%
Revenue 1Y (TTM)1.7%
Revenue growth 3Y20.87%
Revenue growth 5Y14.66%
Sales Q2Q%3.19%

3.2 Future

Based on estimates for the next years, DORM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.84% on average per year.
The Revenue is expected to grow by 4.47% on average over the next years.
EPS Next Y55.02%
EPS Next 2Y30.05%
EPS Next 3Y22.84%
EPS Next 5YN/A
Revenue Next Year3.5%
Revenue Next 2Y3.49%
Revenue Next 3Y4.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.98, which indicates a rather expensive current valuation of DORM.
DORM's Price/Earnings is on the same level as the industry average.
DORM is valuated rather cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 16.10 indicates a correct valuation of DORM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DORM indicates a slightly more expensive valuation: DORM is more expensive than 61.45% of the companies listed in the same industry.
DORM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.98
Fwd PE 16.1
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than 71.08% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DORM is valued a bit more expensive than 68.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.31
EV/EBITDA 12.32
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DORM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
DORM's earnings are expected to grow with 22.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)12.48
EPS Next 2Y30.05%
EPS Next 3Y22.84%

0

5. Dividend

5.1 Amount

DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (2/21/2025, 8:14:18 PM)

After market: 123.59 0 (0%)

123.59

-2.9 (-2.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners81.24%
Inst Owner Change-87.61%
Ins Owners14.98%
Ins Owner Change-17.53%
Market Cap3.77B
Analysts82
Price Target137.45 (11.21%)
Short Float %1.82%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.79%
Min EPS beat(2)25.8%
Max EPS beat(2)37.78%
EPS beat(4)4
Avg EPS beat(4)32.2%
Min EPS beat(4)9.36%
Max EPS beat(4)55.86%
EPS beat(8)4
Avg EPS beat(8)7.6%
EPS beat(12)5
Avg EPS beat(12)4.42%
EPS beat(16)7
Avg EPS beat(16)4.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-1.81%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)4
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)0.98%
PT rev (1m)0%
PT rev (3m)14.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE 16.1
P/S 1.91
P/FCF 21.31
P/OCF 17.2
P/B 3.06
P/tB 7.44
EV/EBITDA 12.32
EPS(TTM)6.51
EY5.27%
EPS(NY)7.68
Fwd EY6.21%
FCF(TTM)5.8
FCFY4.69%
OCF(TTM)7.18
OCFY5.81%
SpS64.54
BVpS40.45
TBVpS16.62
PEG (NY)0.35
PEG (5Y)12.48
Profitability
Industry RankSector Rank
ROA 7.86%
ROE 15.05%
ROCE 15.75%
ROIC 11.76%
ROICexc 12.05%
ROICexgc 20.08%
OM 14.41%
PM (TTM) 9.43%
GM 39.54%
FCFM 8.98%
ROA(3y)6.23%
ROA(5y)7.1%
ROE(3y)12.27%
ROE(5y)12.03%
ROIC(3y)9.08%
ROIC(5y)9.73%
ROICexc(3y)9.38%
ROICexc(5y)10.58%
ROICexgc(3y)15.09%
ROICexgc(5y)14.83%
ROCE(3y)13.5%
ROCE(5y)13.65%
ROICexcg growth 3Y0.77%
ROICexcg growth 5Y-5.08%
ROICexc growth 3Y-10.74%
ROICexc growth 5Y-12.1%
OM growth 3Y-0.77%
OM growth 5Y-7.46%
PM growth 3Y-11.86%
PM growth 5Y-13.36%
GM growth 3Y0.43%
GM growth 5Y-1.52%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.03
Debt/EBITDA 1.52
Cap/Depr 74.31%
Cap/Sales 2.15%
Interest Coverage 7.52
Cash Conversion 64.33%
Profit Quality 95.26%
Current Ratio 2.34
Quick Ratio 1.16
Altman-Z 4.28
F-Score8
WACC9.41%
ROIC/WACC1.25
Cap/Depr(3y)73.79%
Cap/Depr(5y)76.73%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.07%
Profit Quality(3y)63.94%
Profit Quality(5y)79.58%
High Growth Momentum
Growth
EPS 1Y (TTM)63.57%
EPS 3Y9.48%
EPS 5Y1.52%
EPS Q2Q%40%
EPS Next Y55.02%
EPS Next 2Y30.05%
EPS Next 3Y22.84%
EPS Next 5YN/A
Revenue 1Y (TTM)1.7%
Revenue growth 3Y20.87%
Revenue growth 5Y14.66%
Sales Q2Q%3.19%
Revenue Next Year3.5%
Revenue Next 2Y3.49%
Revenue Next 3Y4.47%
Revenue Next 5YN/A
EBIT growth 1Y66.71%
EBIT growth 3Y19.94%
EBIT growth 5Y6.11%
EBIT Next Year62.99%
EBIT Next 3Y22.76%
EBIT Next 5YN/A
FCF growth 1Y646.7%
FCF growth 3Y6.48%
FCF growth 5Y25.95%
OCF growth 1Y321.69%
OCF growth 3Y11.16%
OCF growth 5Y21.73%